Anti-Nausea Drug Bendectin Linked to Increased Colorectal Cancer Risks: Study
Bendectin contains dicyclomine, an active ingredient used in the anti-nausea drug thalidomide, which was linked to severe birth defects.
Bendectin contains dicyclomine, an active ingredient used in the anti-nausea drug thalidomide, which was linked to severe birth defects.